LabGenius
formerly LabGenius TherapeuticsLabGenius Therapeutics | ML-driven Antibody Discovery
London, United Kingdom · $15.1M raised
- Headquarters
- London
- Employees
- 51–200
- Business Model
- B2B
- Website
- labgeniustx.com
- Total Funding
- $15.1M
- Last Round
- $15.0M Venture RoundMay 2024
- Rounds
- 5
About
LabGenius Therapeutics is a drug discovery company using machine learning and automation to identify next-generation therapeutic antibodies.
Summary
LabGenius is an Artificial Intelligence company based in London, United Kingdom. It has raised $15.1M in total across 5 rounds, most recently a $15.0M Venture Round round in May 2024. Investors include Atomico, Lux Capital and Obvious Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Sign up to see all 5 rounds
Seed through Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/labgenius"><img src="https://indexed.vc/api/badge/company/labgenius" alt="LabGenius on Indexed.vc" width="260" height="76" /></a>
